BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18097389)

  • 21. Correspondence re: T. Fehm et al., Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin. Cancer Res., 8: 2073-2084, 2002.
    Fiegl M; Kircher B; Zojer N
    Clin Cancer Res; 2003 Mar; 9(3):1224-5; author reply 1226. PubMed ID: 12631629
    [No Abstract]   [Full Text] [Related]  

  • 22. Circulating tumor cells in colorectal cancer: detection methods and clinical significance.
    Tsouma A; Aggeli C; Pissimissis N; Lembessis P; Zografos GN; Koutsilieris M
    Anticancer Res; 2008; 28(6B):3945-60. PubMed ID: 19192655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Isolation of circulating tumor cells in blood by means of "Isolation by SizE of Tumor cells (ISET)"].
    Liadov VK; Skrypnikova MA; Popova OP
    Vopr Onkol; 2014; 60(5):548-52. PubMed ID: 25816657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Circulating tumor cells: pitfalls and new promises in clinical oncology].
    Hofman P
    Ann Pathol; 2009 Nov; 29 Spec No 1():S25-7. PubMed ID: 19887244
    [No Abstract]   [Full Text] [Related]  

  • 25. Cancer. Fusion for moving.
    Clawson GA
    Science; 2013 Nov; 342(6159):699-700. PubMed ID: 24202164
    [No Abstract]   [Full Text] [Related]  

  • 26. Tumor embolization in man. Studies of cancer cells in the blood.
    West JT; Hume R
    Prog Clin Pathol; 1970; 3():362-82. PubMed ID: 4950009
    [No Abstract]   [Full Text] [Related]  

  • 27. Cell manipulation in microfluidics.
    Yun H; Kim K; Lee WG
    Biofabrication; 2013 Jun; 5(2):022001. PubMed ID: 23403762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissecting T cell lineage relationships by cellular barcoding.
    Schepers K; Swart E; van Heijst JW; Gerlach C; Castrucci M; Sie D; Heimerikx M; Velds A; Kerkhoven RM; Arens R; Schumacher TN
    J Exp Med; 2008 Sep; 205(10):2309-18. PubMed ID: 18809713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hematogenic organ metastasis - which primary tumor?].
    Bassermann R; Ludwig G; Hölzel D; Eder M
    Pathologe; 1984 Jan; 5(1):13-20. PubMed ID: 6701154
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical role of detecting circulating tumor cells.
    Riethdorf S
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S132. PubMed ID: 23083561
    [No Abstract]   [Full Text] [Related]  

  • 31. [From tumor cell to metastasis].
    Poupon MF
    Bull Cancer; 1993; 80(10 Suppl):5-10. PubMed ID: 8081031
    [No Abstract]   [Full Text] [Related]  

  • 32. Tracking CTCs may improve cancer treatment.
    Cancer Discov; 2014 May; 4(5):504. PubMed ID: 24794997
    [No Abstract]   [Full Text] [Related]  

  • 33. Fluorescence-expressing viruses allow rapid identification and separation of rare tumor cells in spiked samples of human whole blood.
    Fong SM; Lee MK; Adusumilli PS; Kelly KJ
    Surgery; 2009 Sep; 146(3):498-505. PubMed ID: 19715807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cancer--a systemic disease].
    Conde J
    Rev Port Estomatol Cir Maxilofac; 1984; 25(2):745-73. PubMed ID: 6533738
    [No Abstract]   [Full Text] [Related]  

  • 35. The direct molecular analysis of metastatic precursor cells in breast cancer: a chance for a better understanding of metastasis and for personalised medicine.
    Klein CA
    Eur J Cancer; 2008 Dec; 44(18):2721-5. PubMed ID: 19022661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
    Riethdorf S; Pantel K
    Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tracking metastasis and tricking cancer.
    Marx V
    Nature; 2013 Feb; 494(7435):133-6. PubMed ID: 23389545
    [No Abstract]   [Full Text] [Related]  

  • 38. Is there a role for circulating tumor cells in the management of breast cancer?
    Hayes DF; Smerage J
    Clin Cancer Res; 2008 Jun; 14(12):3646-50. PubMed ID: 18559576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
    Okegawa T; Nutahara K; Higashihara E
    J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The tumour trail left in blood.
    Chi KR
    Nature; 2016 Apr; 532(7598):269-71. PubMed ID: 27075102
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.